We found that high CLEC14A/PECAM1 and CLEC14A/TIE1 ratios (ratio above 95% of controls) were significantly associated with tumour pathology (odds ratio = 2.5113, 95% CI: 1.7467–3.6104 and odds ratio = 8.9821; 95% CI: 6.7440–11.9630 respectively). Here, PECAM1 is linked to neoplasm.